Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG

Genomics

Volumn 35, Issue 1, 1996, Pages 207-214

  Heighway, Jim ^a   Betticher, Daniel C ^b   Hoban, Paul R ^a   Altermatt, Hans J ^b   Cowen, Rachel ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATASE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CHROMOSOME 12P; DNA DETERMINATION; DNA SEQUENCE; EXON; GENE AMPLIFICATION; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROPHOBICITY; NORTHERN BLOTTING; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0030200901     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1996.0340     Document Type: Article

References (35)

1. Anand, R., Riley, J. H., Butler, J. C., and Markham, A. F. (1990). A 3.5 genome equivalent multi-access YAC library: Construction, characterisation, screening and storage. Nucleic Acids Res. 18: 1951-1956.
2. Beidler, J. L. (1992). Genetic aspects of multidrug resistance. Cancer 70: 1799-1809.
3. Betticher, D. C., Heighway, J., Haselton, P. S., Altermatt, H. J., Ryder, W. D. J., Cerny, T., and Thatcher, N. (1996). Prognostic significance of CCND1 (cyclin D1) overexpression in lung cancer. Br. J. Cancer 73: 294-300.
4. Bos, J. L., Verlan-de Vries, M., Marshall, C. J., Veeneman, G. H., van Boom, J. H., and van der Eb, A. J. (1986). A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene. Nucleic Acids Res. 14: 1209-1217.
5. Chang, E. H., Furth, M. E., Scolnick, E. M., and Lowy, D. R. (1982). Tumourigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature 297: 479-483.
6. Eijdems, E. W. H. M., De Haas, M., Coco-Martin, J. M., Ottenheim, C. P. E., Zaman, G. J. R., Dauwerse, H. G., Breuning, M. J., Twentyman, P. R., Borst, P., and Bass, F. (1995). Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon. Int. J. Cancer 60: 676-684.
7. Filmus, F. J., and Buick, R. N. (1985). Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary. Cancer Res. 45: 4468-4472.
8. Filmus, J., Trent, J. M., Pullano, R., and Buick, R. N. (1986). A cell line from a human ovarian carcinoma with amplification of th K-ras gene. Cancer Res. 46: 5179-5182.
9. Forus, A., Flørenes, V. A., Maelandsmo, G. M., Meltzer, P. S., Fodstad, Ø., and Myklebost, O. (1993). Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: Some amplica do not include MDM2. Cell Growth Differ. 4: 1065-1070.
10. Fujita, J., Srivastava, S. K., Kraus, M. H., Rhim, J. S., Tronick, S. R., and Aaronson, S. A. (1985). Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumours. Proc. Natl. Acad. Sci. USA 82: 3849-3853.
11. George, D. L., Scott, A. F., de Martinville, B., and Francke, U. (1984). Amplified DNA in mouse Y1 drenal tumour cells: Isolation of cDNAs complimentary to an amplified c-Ki-ras gene and localisation of homologous sequence to mouse chromosome 6. Nucleic Acids Res. 12: 2731-2743.
12. Green, E. D., and Olson, M. V. (1990). Systematic screening of yeast artificial chromosome libraries by use of the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87: 1213-1217.
13. Heighway, J., and Hasleton, P. S. (1986). c-Ki-ras amplification in human lung cancer. Br. J. Cancer 53: 285-287.
14. Heighway, J., and Geurts van Kessel, A. H. M. (1987). Isolation of a human genomic fragment, co-amplified with c-Ki-ras, that affects plasmid supercoiling in E. coli. Nucleic Acids Res. 15: 3411-3419.
15. Heighway, J., and Santibanez-Koref, M. F. (1989). Unexpected effects on bacterial phenotype induced by expression of a tumour amplified human sequence. Nucleic Acids Res. 17: 6893-6901.
16. Heighway, J., and Leverton, K. E. (1991). Transcription of a stem/ loop region of a tumour amplified sequence induces bacterial aggregation. J. Gen. Micro. 137: 2313-2319.
17. Heighway, J., Mitchell, E. L. D., Jones, D., White, G. R. M., and Santibanez-Koref, M. F. (1994). A transcribed polymorphism and sub-localisation of MDM2. Hum. Genet. 93: 611-612.
18. Jankowski, S. A., Mitchell, D. S., Smith, S. H., Trent, J. M., and Meltzer, P. S. (1994). SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene 9: 1205-1211.
19. Karlseder, J., Zeillinger, R., Schneeberger, C., Czerwenka, K., Speiser, P., Kubista, E., Birnbaum, D., Gaudray, P., and Theillet, C. (1994). Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 9: 42-48.
20. Krauter, K., Montgomery, K., Yoon, S.-J., LeBlanc-Straceski, J., Renault, B., Marondel, I., Herdman, V., Cupelli, L., Banks, A., Lieman, J., Menninger, J., Bray-Ward, P., Nadkarni, P., Weissenbach, J., Le Paslier, D., Rigault, P., Chumakov, L., Cohen, D., Miller, P., Ward, D., and Kucherlapati, R. (1995). A second generation YAC contig map of human chromosome 12. Nature 377(SuppL): 321-333.
21. Mitsudomi, T., Steinberg, S. M., Oie, H. K., Mulshine, J. L., Phelps, R., Viallet, J., Pass, H., Minna, J. D., and Gazdar, A. F. (1992). ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res. 51: 4999-5002.
22. Nilbert, M., Rydholm, A., Mitelman, F., Meltzer, P. S., and Mandahl, N. (1995). Characterization of the 12q13-15 amplicon in soft tissue tumours. Cancer Genet. Cytogenet. 83: 32-36.
23. Popescu, N. C., Amsbaugh, S. C., DiPaulo, S. C., Tronick, S. R., Aaronson, S. A., and Swan, D. C. (1985). Chromosomal localisation of three human ras genes by in situ molecular hybridisation. Somat. Cell Mol. Genet. 11: 149-155.
24. Program manual for the Wisconsin package, Version 8, September 1994, Genetics Computer Group, 575 Science Drive, Madison, Wisconsin, USA, 53711.
25. Pulciani, S., Santos, E., Long, L. K., Sorrentino, V., and Barbacid, M. (1985). ras gene amplification and malignant transformation. Mol. Cell. Biol. 5: 2836-2841.
26. Reifenberger, G., Reifenberger, J., Ichimura, K., Meltzer, P. S., and Collins, V. P. (1994). Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res. 54: 4299-4303.
27. Ruddock, C., Duncan, L., Center, R., and Garson, O. M. (1993). Coamplification of the gene for parathyroid hormone related protein (PTHRP) and KRAS2 in a human lung cancer cell line. Genes Chromosomes Cancer 7: 213-218.
28. Schwab, M., and Amler, L. C. (1990). Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer. Genes Chromosomes Cancer 1: 181-193.
29. Scott, A. F., Elizaga, A., Morrel, J., Bergen, A., and Penno, M. B. (1994). Characterization of a gene co-amplified with Ki-ras in Y1 murine adrenal carcinoma cells that codes for a putative membrane protein. Genomics 20: 227-230.
30. Slebos, R. J. C., Kibbellar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J. L. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., van Zandwijk, N., Moot, W. J., Bos, J. L., and Rodenhuis, S. (1990). K-RAS oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med. 323: 561-565.
31. Smit, V. T. H. B. M., Boot, A. J. M., Smits, A. M. M., Jan Fleuren, G., Cornelisse, C. J., and Bos, J. M. (1988). KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res. 16: 7773-7782.
32. Stack, M. T., Jones, D., White, G., Liscia, D. S., Venesio, T., Casey, G., Chricton, D., Varley, J., Mitchell, E. D., Heighway, J., and Satibanez-Koref, M. F. (1995). Detailed mapping and LOH analysis suggests a tumour suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Hum. Mol. Genet. 4: 2047-2055.
33. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M. M., and Bos, J. L. (1988). Genetic alterations during colorectal development. N. Engl. J. Med. 319: 525-532.
34. Wright, M. D., and Tomlinson, M. G. (1994). The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15: 588-594.
35. Yamamoto-Hino, M., Sugiyama, T., Hikichi, K., Mattei, M. G., Hasegawa, K., Sekine, S., Sakurada, K., Miyawaki, A., Furuichi, T., Hasegawa, M., and Mikoshiba, K. (1994). Cloning and characterisation of human type 2 and type 3 inositol 1,4,5,-triphosphate receptors. Receptors Channels 2: 9-22.